Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... microbiology and infection diagnostics driven by both the MALDI Biotyper and the newly acquired ELITech Molecular ...

DeutEx is now integrated into the Bruker proteomics ecosystem to support timsTOF, MRMS and MALDI-TOF systems. Dr. Petr Novák, the Head of Structural Biology and Cell Signaling in the Institute of ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare, which ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...

Today we are looking at Danaher (NYSE:DHR) and the best and worst performers in the research tools & consumables industry. The life sciences subsector specializing in research tools and consumables ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...

Today we are looking at Danaher (NYSE:DHR) and the best and worst performers in the research tools & consumables industry ... Founded in 1960, Bruker (NASDAQ:BRKR) designs and manufactures ...